KLKB1 and B-cell chronic lymphocytic leukemia: KLKB1 mRNA is significantly higher in CLL patients than in healthy blood donors and is associated with an increased risk for CLL and will serve as a novel biomarker (2015) (Adamopoulos et al., 2015).